User profiles for Orna Mor

Orna Mor

MOH Israel
Verified email at sheba.health.gov.il
Cited by 4000

Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

…, D Mloka, JL Mokili, B Montes, O Mor… - The Lancet infectious …, 2019 - thelancet.com
Background Global genetic diversity of HIV-1 is a major challenge to the development of HIV
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …

Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

…, F Mhalu, D Mloka, JL Mokili, B Montes, O Mor… - The Lancet …, 2020 - thelancet.com
Background Global HIV-1 genetic diversity and evolution form a major challenge to treatment
and prevention efforts. An increasing number of distinct HIV-1 recombinants have been …

Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in Apoptosis

…, H Kalinski, I Kamer, A Rozen, O Mor… - … and cellular biology, 2002 - Taylor & Francis
Hypoxia is an important factor that elicits numerous physiological and pathological responses.
One of the major gene expression programs triggered by hypoxia is mediated through …

Neutralising capacity against Delta (B. 1.617. 2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers …

…, L Kliker, G Regev-Yochay, E Sapir, O Mor… - …, 2021 - eurosurveillance.org
SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in
Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech…

[HTML][HTML] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1

…, V Indenbaum, L Olmer, A Huppert, O Mor… - Clinical Microbiology …, 2021 - Elsevier
Objectives The immunogenicity and safety of the Pfizer-BioNTech BNT162b2 mRNA vaccine
in people living with human immunodeficiency virus type 1 (PLWH) are unknown. We …

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

…, N Kumarasamy, B Kerschberger, O Mor… - The Lancet infectious …, 2016 - thelancet.com
Background Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through
wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir …

[HTML][HTML] Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021

P Shitrit, NS Zuckerman, O Mor… - …, 2021 - eurosurveillance.org
A nosocomial outbreak of SARS-CoV-2 Delta variant infected 42 patients, staff and family
members; 39 were fully vaccinated. The attack rate was 10.6% (16/151) among exposed staff …

[HTML][HTML] Tracking the international spread of SARS-CoV-2 lineages B. 1.1. 7 and B. 1.351/501Y-V2 with grinch

…, NS Zuckerman, M Mandelboim, O Mor… - Wellcome Open …, 2021 - ncbi.nlm.nih.gov
Late in 2020, two genetically-distinct clusters of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) with mutations of biological concern were reported, one in the United …

Global disparities in SARS-CoV-2 genomic surveillance

…, V Sintchenko, NS Zuckerman, O Mor… - Nature …, 2022 - nature.com
Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize
molecular tests, treatments, vaccines, and guide public health responses. To investigate …

[HTML][HTML] Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel

…, O Erster, A Sela-Brown, D Sofer, O Mor… - Science of The Total …, 2021 - Elsevier
Investigation of SARS-CoV-2 spread and identification of variants in sewers has been
demonstrated to accurately detect prevalence of viral strains and is advantageous to clinical …